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Abstract The K1L1 integrin is a major cell surface receptor for
collagen. Ligand binding is mediated, in part, through a V200
amino acid inserted ‘I’-domain contained in the extracellular part
of the integrin K chain. Integrin I-domains contain a divalent
cation binding (MIDAS) site and require cations to interact with
integrin ligands. We have determined the crystal structure of
recombinant I-domain from the rat K1L1 integrin at 2.2 Aî
resolution in the absence of divalent cations. The K1 I-domain
adopts the dinucleotide binding fold that is characteristic of all I-
domain structures that have been solved to date and has a
structure very similar to that of the closely related K2L1 I-
domain which also mediates collagen binding. A unique feature of
the K1 I-domain crystal structure is that the MIDAS site is
occupied by an arginine side chain from another I-domain
molecule in the crystal, in place of a metal ion. This interaction
supports a proposed model for ligand-induced displacement of
metal ions. Circular dichroism spectra determined in the presence
of Ca2+, Mg2+ and Mn2+ indicate that no changes in the
structure of the I-domain occur upon metal ion binding in
solution. Metal ion binding induces small changes in UV
absorption spectra, indicating a change in the polarity of the
MIDAS site environment.
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1. Introduction
Integrins are a family of large plasma membrane proteins
involved in processes of cell-cell and cell-extracellular matrix
adhesion and signal transduction. They exist as non-covalent
KL heterodimers consisting of di¡erent combinations of K and
L chains. Currently more than 16 K chains and eight L chains
are known. Many K chains contain in their extracellular re-
gion a V200 amino acid inserted domain, known as the I-
domain or A-domain. This domain is homologous to the von
Willebrand factor (vWF) A-domain as well as domains that
exist in other proteins such as complement factor B. Ligand
binding of the I-domain-containing integrins appears to be
mainly mediated through their I-domains, in a metal ion-de-
pendent process [1^4]. Recombinant I-domains retain many of
the metal ion and ligand binding properties of the parent
integrin and thus are frequently used as models for studying
integrin function [5^8]. Native integrins undergo an activation
step that increases their a⁄nity for their ligand, which can be
mimicked through the addition of Mn2 or certain speci¢c
antibodies. While the mechanism leading to activation is not
well understood, it is believed to occur, at least in part,
through conformational changes of the integrin.
Crystal structures have been solved for the I-domains of the
KM, KL and K2 integrin chains in the presence or absence of
divalent cations [9^15]. In all structures the I-domain adopts
the Rossmann or dinucleotide binding fold with a central six-
stranded L-sheet surrounded by seven K-helices. A metal ion
binding site exists at one end of the L-sheet formed by residues
from a conserved sequence motif DXSXS as well as two addi-
tional conserved residues, a D and a T. This site is known as
metal ion-dependent adhesion site (MIDAS) and is implicated
in ligand binding. Two modes of metal ion coordination in the
MIDAS site have been observed in the available crystal struc-
tures of I-domains. The ¢rst one (‘open’) has been observed
only in one crystal form and includes coordination of the
metal ion by a glutamate residue from a neighboring molecule
in the crystal [9,15]. The second one (‘closed’) has been ob-
served in all other crystal forms. These di¡erences in metal ion
coordination are associated with di¡erences in the conforma-
tion of the I-domain, involving a signi¢cant shift of the C-
terminal helix and other rearrangements of residues proximal
to the MIDAS site. Extensive mutagenesis work and analysis
of chimeric I-domains have demonstrated that several residues
surrounding the MIDAS site are also part of the ligand bind-
ing site [16].
The K1L1 integrin (very late antigen-1; VLA-1) is expressed
on a variety of cell types including those of hematopoietic,
neuronal and mesenchymal origin. Together with K2L1 it be-
longs to a subset of integrins that both bind to collagen I,
collagen IV and laminin but with di¡erent a⁄nities [17^19].
K1L1 integrin binds to collagen IV with higher a⁄nity than to
collagen I while the reverse is true for K2L1. These two integ-
rins are also known to recognize di¡erent but adjacent sites
within collagen IV [20]. A study [21] identi¢ed Arg-461 of the
collagen K2(IV) chain and Asp-461 within the K1(IV) chain as
essential residues for K1L1 binding. A chimeric K1 chain, in
which the I-domain has been replaced with the K2 I-domain,
has a ligand binding pro¢le similar to that of the K2L1 integ-
rin [22]. The crystal structure of the K2 I-domain showed the
presence of a small helix (C-helix), adjacent to the MIDAS
motif, which is a unique structural feature of the K1 and K2 I-
domain subfamily. Modeling of collagen triple helix bound to
the K2 I-domain suggested that the C-helix may be an impor-
tant structural determinant of collagen binding and speci¢city
[11].
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To gain more in-depth perspective on this integrin subfam-
ily, we have determined the crystal structure of the rat K1
I-domain in the apo state at 2.2 Aî resolution and directly
compared it to the K2 I-domain structure. In addition, we
probed the e¡ect of divalent cations in the structure of the
I-domain in solution, by optical spectroscopy.
2. Materials and methods
2.1. Expression and puri¢cation of the K1 integrin I-domain
Details of the cloning, expression and puri¢cation of the K1 integrin
I-domain will be discussed elsewhere (Gotwals et al., submitted for
publication). Brie£y, the DNA encoding the I-domain fragment of the
extracellular domain of the rat K1 integrin chain (amino acid sequence
Val-127^Ala-340, referred to as K1-I in subsequent text) was ampli¢ed
from full length cDNAs by PCR. The resulting PCR ampli¢ed prod-
uct was puri¢ed, ligated in pGEX4t expression vector (Pharmacia)
and transformed into competent DH5K Escherichia coli cells (Gibco
BRL). The K1 I-domain was expressed as a GST fusion protein with a
thrombin cleavage site at the junction of the sequences. For prepara-
tion of the puri¢ed K1 I-domain, the fusion protein was treated with
thrombin and the I-domain was puri¢ed by standard techniques. The
puri¢ed I-domain was s 99% pure by SDS-PAGE, eluted as a single
peak by size exclusion chromatography on a Superose 6 column
(Pharmacia and Upjohn) and displayed its predicted mass (24 871
Da) by electrospray ionization-mass spectrometry (ESI-MS).
In preliminary studies, we found that the rat K1 integrin I-domain
in this form failed to crystallize under any test condition, and, as had
been observed for other I-domains (R. Liddington, personal commu-
nication), that sequences at the N-terminus of the I domain construct
were problematic. A simple proteolytic method was developed to con-
vert the puri¢ed rat I-domain into a form that could be crystallized.
Brie£y, 240 Wl of the puri¢ed K1 integrin I-domain (16 mg/ml) was
diluted with 360 Wl of 50 mM Tris-HCl pH 7.5 and loaded onto a 1.2
ml V8 protease column (Pierce) that had been equilibrated in 50 mM
Tris-HCl pH 7.5. The I-domain solution was left in contact with the
resin for 35 min at room temperature and then recovered by washing
the column with 50 mM Tris-HCl pH 7.5. The I-domain was then
dialyzed overnight against 10 mM Tris pH 7.5, 10 mM 2-mercaptoe-
thanol and concentrated to 11 mg/ml in a Centricon-10 ultra¢ltration
unit (Amicon). ESI-MS analysis of the V8 protease-digested product
revealed that the product had been converted into a des 1^18 form,
starting at Cys-143 in the fusion protein construct.
2.2. Crystallization and structure determination
Crystallization condition screenings were done with the Crystal
Screen I kit from Hampton Research (Riverside, CA). In order to
¢nd conditions of crystallization, an incomplete factorial screen was
set up. Crystals were grown by the vapor di¡usion method [23], out of
25% w/v polyethylene glycol (PEG) 8000, 0.1 M sodium cacodylate
pH 6.5, 0.2 M sodium acetate reservoir solution. The crystals are plate
shaped and can reach maximum dimensions of almost 0.5 mm on one
side.
Crystals were equilibrated gradually in a cryoprotectant solution of
20% glycerol, 25% w/v PEG 8000, 0.1 M sodium cacodylate pH 6.5,
0.2 M sodium acetate, and were mounted on a loop and immediately
frozen in a 3150‡ C liquid nitrogen gas stream. A native X-ray data
set up to 3.0 Aî resolution was collected from one crystal by using an
R-AXIS II image plate detector system (Molecular Structure Corpo-
ration, Woodlands, TX). A second data set to 2.2 Aî resolution was
collected later by using a larger crystal. The data were integrated and
reduced using the HKL program package [24]. Data processing sug-
gested an orthorhombic unit cell with approximate cell dimensions
a = 34.77 Aî , b = 85.92 Aî , c = 132.56 Aî and K= L= Q= 90‡. The space
group was identi¢ed as P212121. The 2.2 Aî data set was 91.3% com-
plete (77.6% for 2.2^2.28 Aî shell) with an I/c(I) of 19.98 (3.14 for 2.2^
2.28 Aî shell) and an R-merge of 5.6%. The Matthews volume [25] is
4.22 Aî 3 Da31, assuming a molecular weight of 23 000 Da which sug-
gested that there are two molecules in the asymmetric unit.
All molecular replacement computing was done with the program
AMoRe [26] from the CCP4 program package [27]. Molecular
graphics manipulations were done with programs QUANTA (Molec-
ular Simulations, Inc., San Diego, CA) and ‘O’ [28]. The coordinates
of the crystal structure of the human K2 I-domain [11] were used as a
probe for rotation and translation searches using the 3 Aî data set. The
rotation function gave a solution with the highest correlation coe⁄-
cient (cc) of 9.7. This solution was used for a translation function
calculation that yielded a maximum peak with a cc of 24.6 and an
R-factor of 48.7. The translation search for the second molecule, while
keeping the ¢rst solution ¢xed, yielded a maximum peak with cc of
37.3 and an R-factor of 44.8%. Rigid body re¢nement on these two
solutions resulted in a cc of 56.3 and an R-factor of 43.3%. The next
highest solution had a cc = 36.6 and an R-factor = 49.9%. The rotation
matrix between the two molecules of the asymmetric unit was deter-
mined and one molecule was used for the initial stages of model
building.
Subsequent re¢nement computing was done with the XPLOR pro-
gram [29]. 10% of the 8^3 Aî data were used for the calculation of R-
free. To reduce model bias, partial models were used for 3Fo-2Fc map
calculation and model re¢nement. The initial partial model, contain-
ing a polyalanine chain of the secondary structure elements from the
K2 I-domain structure, was subjected to positional and grouped B-
factor re¢nement with strict non-crystallographic symmetry con-
straints. The R and R-free factors dropped to 32.3% and 39.4% re-
spectively. Several cycles consisting of model building, positional re-
¢nement and B-factor re¢nement followed. When the R and R-free
reached 26% and 36% respectively, no further improvement of the
model could be achieved with the 3 Aî data set. The 2.2 Aî data set
was collected at this point and was used for all subsequent model
building and re¢nement. The R and R-free factors after the initial
rigid body re¢nement at 2.2 Aî were 41.3% and 42.2%, respectively.
This larger data set allowed use of simulated annealing and torsion
angle dynamics re¢nement. As the phases improved, more atoms were
added into the model. Initially, grouped B-factors were assigned for
each residue (one for main chain and the one for side chain atoms).
Later, non-crystallographic symmetry constraints were removed and
individual atomic B-factors were re¢ned for each residue. In addition,
bulk solvent correction was applied to the data set. Residues and side
chains would be incorporated in the model if they were su⁄ciently
well de¢ned in 3Fo-2Fc electron density maps. Only manual structure
modi¢cations that resulted in lower R-free after re¢nement were ac-
cepted. When R and R-free reached 29% and 34.8%, respectively,
water molecules were added by using the X-solvate utility of QUAN-
TA. Finally, maximum likelihood re¢nement was used [30] and re-
sulted in the ¢nal structure with R and R-free of 23.4% and 29.9%
respectively for data between 100 and 2.2 Aî resolution. The atomic
coordinates and structure factors have been deposited in the Protein
Data Bank (entry codes 1ck4 and r1ck4sf).
2.3. Optical spectroscopy
Circular dichroism (CD) spectra were recorded at 10‡C using a J-
710 spectropolarimeter (JASCO, Japan). The CD spectrum of the rat
K1-I domain was measured at a protein concentration of 55 WM in 20
mM HEPES, 1 mM EDTA, 1 mM DTT, pH 7.5 in the absence of
divalent cations, or the presence of either 2 mM Ca2, Mg2 or Mn2.
CD spectra were recorded using a scan speed of 20 nm/min, a re-
sponse time of 2 s and a bandwidth of 2 nm for far- and 1 nm for
near-UV measurements. Typically, ¢ve spectra were accumulated and
subsequently averaged. Neither noise reduction nor smoothing pro-
grams were applied to the spectra in the near-UV range.
UV absorption spectra were measured at 25‡C using a DU 640
spectrophotometer (Beckman, USA). Protein concentration was de-
termined using a molar absorptivity of 12 950 M31 cm31 at 280 nm as
it was calculated assuming molar absorptivities of 5500 M31 cm31 per
tryptophan and 1490 M31 cm31 per tyrosine residue [31]. The spectra
were corrected for turbidity by plotting the dependence of the log10 of
the absorbance of the solution versus the log10 of the wavelength and
extrapolating the linear dependence between these quantities in the
range 340^440 nm to the absorption range 240^300 nm. The extrapo-
lated values were then subtracted from the measured values.
3. Results and discussion
3.1. Description of structure
We have expressed the I-domain of the rat K1 integrin chain
in E. coli as a GST fusion protein. The recombinant protein
bound type IV collagen and type I collagen in a metal ion-
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dependent manner and this interaction could be blocked with
a neutralizing antibody raised against K1L1 or with EDTA
(Gotwals et al., submitted for publication). Crystals of the
K1 I-domain were grown and the structure was determined
by molecular replacement at 2.2 Aî resolution. The asymmetric
unit of the crystal contains two I-domain molecules, referred
to as molecules A and B. Almost all main chain amino acids,
except for residues 143^144 of the N-terminus and 336^340 of
the C-terminus, are well de¢ned in the ¢nal electron density
map (Fig. 1). There is no electron density for the side chain of
residues Thr-145, Gln-146, Arg-234 of molecule A and Thr-
145 and Arg-175 of molecule B. The current model consists of
386 amino acid residues and 215 water molecules. The stereo-
chemistry of the model was analyzed with the program PRO-
CHECK [32]. The Ramachandran diagram shows that all
amino acid residues except Glu-192 have P, i angles within
the allowed regions. The root mean square (rms) deviations
from ideal values for bonds and angles are 0.009 Aî and 1.55‡,
respectively.
The K1 I-domain adopts the classic dinucleotide or Ross-
mann fold characterized by a central L-sheet consisting of ¢ve
parallel and one antiparallel L-strands surrounded by seven
amphipathic K-helices. The molecule presents the ‘closed’ con-
formation previously observed in most crystal forms of I-do-
mains that have been solved to date [15]. The structure of the
K1 I-domain is very similar to that of the K2 I-domain (se-
quence identity 49.5%). The rms positional variation of CK
atoms of superimposed K1 I and K2 I is 0.8 Aî . The rms
deviation between 1294 equivalent (conserved in both struc-
tures) atoms is 1.3 Aî . The biggest di¡erences between K1 and
K2 I-domains are shifts in the C-terminal K7 helix that can
reach up to 2 Aî for the last few main chain atoms of the helix.
The conformations of molecules A and B are very similar. The
rms deviations in CK positions between molecules A and B
are 0.4 Aî . The overall rms deviations are 1.0 Aî . Most of the
structural di¡erences are rotameric shifts of surface side
chains.
The structural di¡erences between the two conformations of
I-domain are dominated by the exposure to the solvent of two
buried phenylalanines (Phe-275 and Phe-302 in the KM se-
quence) [12]. In the K1 I-domain crystal structure, a glutamic
acid (Glu-321), located at the top of the K7 helix, replaces the
Phe-302 of the KM I-domain. There is also a water molecule
(191), not found in I-domains other than K2 I, which makes
hydrogen bonds to Glu-321, the main chain nitrogen of His-
288 and the MIDAS site Asp-257. However, in K1 I, this
water molecule is observed only for molecule B. With respect
to the second phenylalanine (Phe-275 of KM I), despite the
large local structural di¡erences between the KM I and K1 I
due to a longer loop, there is a similar hydrophobic pocket in
K1-I occupied by Phe-299. This Phe residue is located on the
K6 helix, while Phe-275 in KM I is located on middle of the
Fig. 1. Representative portion of the ¢nal 2Fo-Fc electron density map. The map is contoured at 1.0 c and superimposed on corresponding
atoms from the ¢nal re¢ned model. The ¢gure was made with QUANTA.
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LE-K6 loop. However, the phenyl ring of Phe-299 is in a very
similar position to that of Phe-275 of KM I.
Unlike with other I-domains, the K1 I and K2 I structures
contain a short 1.5 turn K-helix on the LE-K6 loop (the C-
helix loop) that protrudes from the MIDAS face. The con-
formation of the C-helix loop (residues 286^296) of the K1 I is
remarkably similar to that of the K2 I. The rms deviations
between K1 I and K2 I C-helix loops are 0.78 Aî for the CK
positions and 1.24 Aî for all equivalent atoms. Tyr-285 of the
K2 I is replaced with His-288 that adopts the same side chain
conformation. Leu-286 of the K2 I is replaced by Tyr-289 that
is stabilized by a hydrogen bond with the main chain nitrogen
of Glu-259. These residues could play a role in di¡erent col-
lagen speci¢city, since they are the only ones close to the
MIDAS site that are di¡erent between the K1 and K2 I-do-
mains.
3.2. The MIDAS site
The residues of the MIDAS site of the K1 I-domain (Asp-
154, Ser-156, Ser-158, Thr-224 and Asp-257) are relatively
well de¢ned in the electron density map. The crystals of K1
I were grown in the absence of divalent cations. There is no
electron density in the MIDAS site of both molecule A and B
that would correspond to a divalent cation due to contami-
nants. A simulated annealing omit map, calculated by omit-
ting all the residues within an 8 Aî sphere from the expected
cation position, did not reveal any electron density feature
that could correspond to bound cation. There are only minor
di¡erences in the conformation of the MIDAS site residues to
those of the K2 I structure with bound Mg2. Similarly, no
major di¡erences were observed in the MIDAS site of the KL
I with and without cation [13]. Minor di¡erences are ob-
served, such as a rotation of the side chain of Asp-154 that
results in ON1 of Asp-154 being 4 Aî , instead of 2.6 Aî , away
from Ser-156 OH.
Of particular interest is a crystal contact interaction formed
between the MIDAS site of molecule A and Arg-246 of mol-
ecule B (Fig. 2). The NR1 atom of Arg-246 makes H-bonds
with Ser-156 and Ser-158. The same atom also lies in a posi-
tion very close to that of a water molecule that interacts with
the Mg2 ion in the K2 I structure. Only one of the three
water molecules that would normally interact with the metal
ion is present. The NR2 atom of Arg-246 makes an H-bond
with Thr-224. Thus Arg-246 seems to have some of the prop-
erties of a ligand mimetic and in the absence of divalent cat-
ions, the positive charge of the arginine may substitute the
missing metal ion. Therefore this interaction might represent
an intrinsic a⁄nity of the MIDAS site for positively charged
groups. This notion is consistent with the presence of an ex-
tensive negative electrostatic potential demonstrated with cal-
culations using GRASP [33] (data unpublished). Indeed, in-
teraction with a positively charged amino acid (Lys-181 of
molecule B) is observed for molecule A too. While the pres-
ence of a positive charge in this site was not emphasized
previously, on close examination of another available crystal
structure of an I-domain without metal ion (KL I structure,
PDB entry code 1zon) [13] we observed that the MIDAS site
interacts with Lys-188 of a neighboring molecule. In particu-
lar, the Nj1 atom of the Lys-188 forms H-bonds with the two
serine residues of the MIDAS site in the similar manner as the
NR1 atom of Arg-246 in the K1 I structure.
Integrin ligands typically contain a critical acidic residue
such as a glutamate or an aspartate. It has been proposed
that the acidic residue coordinates the metal ion bound on
the MIDAS motif during the ligand-integrin interaction [12].
Indeed, in a crystal structure of the KM I-domain, a glutamate
residue from a neighboring molecule was observed to coordi-
nate the Mg2 ion in the MIDAS site [9]. It is striking that the
I-domain of this particular crystal structure adopted an ‘open’
conformation di¡erent from all other observed I-domain
structures, involving a signi¢cant shift of the C-terminal helix
and other rearrangements of residues proximal to the MIDAS
site. Because integrins are known to undergo activation, and
this in part is likely to occur through conformational changes,
it was proposed that this particular crystal structure repre-
sented the active state of the I-domain while the other struc-
tures represent the inactive state [12]. Since all other crystal
structures of I-domains adopted the ‘closed’ conformation in
the presence or absence of cation, it was hypothesized that the
glutamate, acting as a ligand mimetic, and not the cation,
induced the conformational change. No crystal structure of
an I-domain complex with its ligand has been determined up
to date, therefore this issue remains highly controversial.
While the proposed model [12] supports a state where li-
gand binding is through the metal ion in the MIDAS site,
various studies suggest that the metal ion is either displaced
upon ligand binding or in selected instances is not required for
ligand binding at all. The following highlights some of these
observations. In a recent study [34], the authors proposed a
model in which the divalent cation is required for initial bind-
ing of the K2 I to collagen and that subsequent metal ion
displacement occurs to generate a metal free I-domain ligand
complex. The experiment involved use of Tb3 £uorescence
and demonstrated that Tb3 supported ligand binding. We
have observed similar e¡ects with the K1 I-domain (unpub-
lished data). These observations suggest the formation of a
ligand-bound subsequent state of the I-domain in which the
divalent cation has been displaced, a model that has also been
proposed for the binding of RGD ligands to KIIbL3 integrin
[35]. The displacement of the cation may be a consequence of
substitution of the acidic residue of the ligand and the metal
ion that is bound to the MIDAS site, with a neighboring
positively charged residue such as arginine. Interestingly, an
arginine residue is frequently proximal to the acidic residue
and essential for binding in many integrin ligands such as in
RGD-containing proteins, collagen IV [21], collagen I [36] and
VCAM-1 [37]. While the details of the mechanism leading to
ligand-induced displacement of the metal ion are unknown,
one possibility is that the model of interaction of the ligand
acidic group with the cation in this ‘activated’ state [12] rep-
resents a transient intermediate in the process (Fig. 3). A
prediction of this model is that the ligand-bound (IL), met-
al-bound (I) and unoccupied form (I) are of similar energy
states, which would facilitate the subsequent release of the
ligand from the bound state and cycling of the process.
Several reports suggest that the I-domain can bind inde-
pendently of cation, which is consistent with our model. In
this situation the positively charged amino acid is acting as a
ligand mimetic in the absence of cation. First, data for bind-
ing of recombinant K2 I-domain to collagen [4] suggest that
divalent cations are not absolutely required for binding. It was
proposed [11] that the iodination of a tyrosine residue of that
study may favor a high a⁄nity state of the I-domain, abro-
gating the need for a metal ion. In addition, in a recent muta-
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genesis study, it was proposed that the I-domain exists in
solution in equilibrium between two a⁄nity states that can
be modulated both positively or negatively by certain muta-
tions [15].
Second, alanine substitution of MIDAS residues Asp-151
and Asp-254 of the K2 I-domain had minimal or no e¡ect
on collagen binding, while alanine substitution of Thr-221
resulted in loss of collagen binding [4]. It is interesting that
the interaction of Arg-246 with the MIDAS site of K1 I in-
volves an H-bond with the MIDAS threonine and no H-
bonds with the two MIDAS aspartates.
Third, recently a cyclic peptide (CTRKKHDNAQC) was
identi¢ed that competes with K2 I-domain binding to collagen
[38]. Mutational analysis of the peptide showed that a se-
quence of three positively charged amino acids, arginine-ly-
sine-lysine (RKK), is essential for I-domain binding and that
Fig. 2. The crystallographic dimer. a: Ribbon representation of the two I-domain molecules in the asymmetric unit. The Arg-246 residue in-
volved in an interaction with the MIDAS site is also shown. b: Close-up of the Arg-246-MIDAS site interaction. Arg-246 is shown in blue and
MIDAS side chains are shown in red. Hydrogen bonds are shown as dashed lines and lengths are indicated in Aî . The ¢gure was made with
QUANTA.
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mutation of the other amino acids in the peptide had little
e¡ect on binding. It is interesting that the aspartate residue of
the peptide was not necessary for binding of the peptide to the
I-domain.
Two other related systems provide further insights into the
mechanism of I-domain function: vWF A-domains are struc-
turally homologous to integrin I-domains and are known to
bind to collagen. However, they do not require metal cation
for collagen binding and their MIDAS site is only partially
conserved [39,40]. The structure of the vWF A3 domain sug-
gested that binding to collagen is achieved through interac-
tions between negatively charged residues on A3 and posi-
tively charged residues on collagen. It is possible that the
mechanism of binding of I-domain-containing integrins is evo-
lutionarily related and shares some common aspects.
Multiple, allosterically controlled, activation states involv-
ing a cation displacement step are well-established events in
the function of the, apparently closely related, G-proteins. I-
domains, GTP binding proteins (such as Ras) and GK sub-
units adopt a similar type of structural fold, which suggests
that they diverged from a common ancestor. In addition, it
has been proposed that the integrin K chains contain a pro-
peller fold similar to GL subunits of G-proteins [41]. Mecha-
nistic similarities of G-proteins and I-domains in terms of
Mg2 binding and a⁄nity switch mechanism have been ob-
served and described [12]. The recent evidence of cation dis-
placement in integrins resembles the cation displacement in G-
proteins, which suggests further similarity with G-protein
function. It is possible that integrins use such mechanisms
to cycle between low and high a⁄nity states resulting in rapid
adhesion and de-adhesion events necessary for cell migration
[42].
The glutamine-cation-MIDAS site interaction [9] and the
arginine-MIDAS site interaction described here are both con-
sistent with available experimental data and may mimic snap-
shots of a dynamic pathway of the integrin I-domain function.
More detailed biochemical, genetic and crystallographic anal-
ysis is necessary to test these hypotheses.
3.3. Spectroscopy analysis
Because metals are involved in ligand binding and may
e¡ect I-domain structure, we investigated the e¡ects of
Mn2, Ca2 or Mg2 on the secondary and tertiary structure
of the rat K1 I-domain in a comparative study by CD spec-
troscopy. Results from these studies are shown in Fig. 4a for
far- and Fig. 4b for near-UV spectral range. The data from
the far- and near-UV spectra are almost identical, within the
error limit of the measurement, under all test conditions in-
dicating that the secondary and tertiary structure are practi-
cally the same in the apo state and in the presence of divalent
cations. The near-UV spectra are very sensitive to local pro-
tein structure in the vicinity of aromatic residues and therefore
the similarity of these spectra further supports the results ob-
tained by far-UV analysis. Thus, the CD data indicate ab-
sence of structural changes of the I-domain in solution due
to divalent cation binding, supporting the crystallographic
evidence [13,14].
In contrast to the lack of e¡ect of metal binding on the CD
Fig. 4. Optical spectra of the K1 I-domain. a: CD spectrum in the
far-UV range in the presence or absence of di¡erent divalent cati-
ons. b: CD spectrum in the near-UV range. c: UV absorption spec-
trum.
Fig. 3. Schematic of a hypothetical mechanism of ligand binding to
I-domains. I = integrin I-domain, k= metal ion, L = ligand. The
closed conformation of the I-domain is represented with an ellipsoid
and the open with a rectangle.
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spectra, a small change in the absorbance spectra was detected
(Fig. 4c). This suggests that in the presence of divalent cation,
the environment surrounding Trp-162 is more hydrophobic
than in the apo state as evident by a increase in both the
intensity and Imax. This e¡ect could not be accounted for by
turbidity since the largest e¡ect on the spectra was seen in the
280^290 nm spectral range while in the 240^260 nm range a
decrease in intensity was seen. The crystal structure shows
that Trp-162 is buried but located relatively close to the sur-
face of the molecule and V9 Aî away from the expected posi-
tion of the divalent cation. It also lies relatively close to the
top of the K7 helix, the site that may undergo large conforma-
tional changes upon activation. Essentially no di¡erences are
observed in the conformation of this tryptophan residue in the
structures of K1 I and K2 I (Mg2). Thus the changes in the
spectra may be attributable to neutralization of charges due to
cation binding.
In summary, we have determined the crystal structure of the
K1 I-domain in the absence of metal ions and re¢ned it to 2.2
Aî resolution. We reviewed published evidence that I-domains
can interact with ligands independently of metal ions or acidic
residues and proposed a possible interpretation based on an
interaction with an arginine residue observed in the K1 I crys-
tal structure. We have also shown by CD spectroscopy that
metal ion binding in solution does not a¡ect the overall con-
formation of the I-domain.
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